Literature DB >> 24194400

Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis : Generation and inactivation of the chemotactic factor C5a.

D G Wright1, J I Gallin.   

Abstract

During phagocytosis of latex particles human polymorphonuclear leukocytes (PMNs) release a product that generates chemotactic activity from fresh human serum. Release of this product is maximal at 20-30 min of phagocytosis. It is present in resting PMNs, may be recovered from granule fractions, and functions at physiologic pH. Gel-filtration chromatography of the activated serum indicates that C5a accounts for most of the chemotactic activity generated. Studies utilizing preparations of C5, EDTA, magnesium-EGTA, CS-deficient serum, and serum heated for 20 min at 50°C demonstrate that generation of C5a results from activation of the complement system as well as from direct cleavage of C5. Activation of the complement system by this PMN-derived serum activator appears to proceed through both the alternate and classical pathways. In addition to this serum activator, an inactivator of C5a chemotactic activity is also released by the PMNs under certain conditions of phagocytosis. These studies suggest that phagocytizing PMNs have secretory functions that contribute to the localization and amplification of inflammatory responses.

Entities:  

Year:  1975        PMID: 24194400     DOI: 10.1007/BF00918057

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  ADHESION AND EMIGRATION OF LEUKOCYTES PRODUCED BY CATIONIC PROTEINS OF LYSOSOMES.

Authors:  A JANOFF; B W ZWEIFACH
Journal:  Science       Date:  1964-06-19       Impact factor: 47.728

2.  Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity.

Authors:  I Spilberg; B Mandell; R D Wochner
Journal:  J Lab Clin Med       Date:  1974-01

Review 3.  Leukocytic proteases and the immunologic release of lysosomal enzymes.

Authors:  G Weissmann; R B Zurier; S Hoffstein
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes.

Authors:  J I Gallin; R A Clark; H R Kimball
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

6.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

7.  The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly.

Authors:  J I Gallin; A S Rosenthal
Journal:  J Cell Biol       Date:  1974-09       Impact factor: 10.539

8.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

9.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Molecular aspects of the phagocytosis resistance of group A streptococci.

Authors:  B N Manjula
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

2.  Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease.

Authors:  J I Gallin; E S Buescher
Journal:  Inflammation       Date:  1983-09       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.